Related Experiment Video
Updated: May 30, 2026

Valorization of the Red Seaweed Gracilaria gracilis Through a Biorefinery Approach
Published on: November 21, 2023
Bioactivities from marine algae of the genus Gracilaria
Cynthia Layse F de Almeida1, Heloina de S Falcão, Gedson R de M Lima
1Department of Pharmaceutical Sciences, Laboratory of Pharmaceutical Technology, Federal University of Paraiba, João Pessoa, PB 58051-900, Brazil; E-Mails: cynthialayse@gmail.com (C.L.F.A.); heloinafalcao@yahoo.com.br (H.S.F.); gedson@ltf.ufpb.br (G.R.M.L.); camila_montenegro@ltf.ufpb.br (C.A.M.); narlizelira@yahoo.com.br (N.S.L.); athayde-filho@quimica.ufpb.br (P.F.A.-F); lcezar@ltf.ufpb.br (L.C.R.); mfvanderlei@ltf.ufpb.br (M.F.V.S.); jbarbosa@ltf.ufpb.br (J.M.B.-F.).
Abstract:
Seaweeds are an important source of bioactive metabolites for the pharmaceutical industry in drug development. Many of these compounds are used to treat diseases like cancer, acquired immune-deficiency syndrome (AIDS), inflammation, pain, arthritis, as well as viral, bacterial, and fungal infections. This paper offers a survey of the literature for Gracilaria algae extracts with biological activity, and identifies avenues for future research. Nineteen species of this genus that were tested for antibacterial, antiviral, antifungal, antihypertensive, cytotoxic, spermicidal, embriotoxic, and anti-inflammatory activities are cited from the 121 references consulted.
Related Concept Videos
Other Algae
Red Algae
Green Algae
Overview of Algae
Biofuels
Marine Microbial Ecology

